Liven Pharmaceuticals Limited (PSX:LIVEN)

Liven Pharmaceuticals Cash Flow Statement

Financials in millions PKR. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Net Income	107.8	-11.18	-12.33	-14.29	-14.63	-16.93
Depreciation & Amortization	22.8	11.79	13.1	14.56	16.08	17.87
Other Operating Activities	-32.07	-2.61	-2.9	-3.22	-3.55	-3.09
Change in Accounts Payable	16.56	-	-	-0.07	-4.16	-
Change in Other Net Operating Assets	10.92	1.12	-0.14	0.76	-0.52	0.26
Operating Cash Flow	-230.29	-0.88	-2.27	-2.26	-6.79	-1.89
Short-Term Debt Issued	-	0.89	2.27	2.24	6.79	1.91
Total Debt Issued	226.53	0.89	2.27	2.24	6.79	1.91
Net Debt Issued (Repaid)	21.89	0.89	2.27	2.24	6.79	1.91
Financing Cash Flow	21.89	0.89	2.27	2.24	6.79	1.91
Net Cash Flow	0.05	0.01	0	-0.02	-0.01	0.03
Levered Free Cash Flow	-236.4	4.29	3.45	4.31	0.03	9.85
Unlevered Free Cash Flow	-236.39	4.29	3.45	4.31	0.03	9.85
Change in Net Working Capital	244.98	-1.12	0.14	-0.7	4.69	-4.49

Source: S&P Global Market Intelligence. Standard template. Financial Sources.